← All organizations

Artiva Biotherapeutics, Inc.

For profitWebsite ↗

Also known as: Artiva Biotherapeutics | Artiva Biotherapeutics, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Jul 9, 2025

Timeline

2010s

Jun 1, 2019
Artiva Biotherapeutics, Inc.— Founded

Drugs by trial phase (9 distinct, 7 trials)

Phase 2 (8 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

obinutuzumab

Indications

Studied for

Recent trials (10)

NCT06991114Lead sponsorPhase 2Jul 9, 2025
NCT06699771CollaboratorPhase 1Dec 31, 2024
NCT06581562CollaboratorPhase 1May 15, 2024
NCT06265220Lead sponsorPhase 1Apr 3, 2024
NCT06265220OfficialPhase 1Apr 3, 2024
NCT05883449CollaboratorPhase 2Oct 10, 2023
NCT05678205Lead sponsorPhase 1/Phase 2Aug 1, 2023
NCT05678205Study directorPhase 1/Phase 2Aug 1, 2023
NCT04673617Lead sponsorPhase 1/Phase 2Dec 29, 2020
NCT04673617Study directorPhase 1/Phase 2Dec 29, 2020

Details

Founded: San Diego, CA, US Jun 1, 2019
Last known activity: Jul 9, 2025